Sign in

CIK 0001410098

  • Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
  1. 4 Open-market sale Chief Legal Officer sold 50,000 shares at an average $13.41 ($670,264)
  2. 4 Open-market sale Chief Operating Officer sold 53,997 shares at an average $13.18 ($711,817)
  3. 4/A Shares withheld for taxes Chief Operating Officer gave up 8,424 shares (to pay taxes)
  4. 4/A Shares withheld for taxes Chief Legal Officer gave up 8,880 shares (to pay taxes)
  5. 4 Grant or award Chief Operating Officer acquired 69,686 shares (grant or award)
  6. 4 Grant or award Chief Legal Officer acquired 69,686 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 69,686 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  10. 4 Exercise or conversion Chief Executive Officer acquired 59,170 shares (option exercise)
  11. 4 Shares withheld for taxes Chief Executive Officer gave up 23,977 shares (to pay taxes)
  12. 4 Grant or award Director acquired 25,000 shares (grant or award)
  13. 4 Grant or award Director acquired 25,000 shares (grant or award)
  14. 4 Grant or award Director acquired 25,000 shares (grant or award)
  15. 4 Grant or award Director acquired 25,000 shares (grant or award)
  16. 4 Grant or award Director acquired 25,000 shares (grant or award)
  17. 4 Grant or award Director acquired 25,000 shares (grant or award)
  18. 4 Shares withheld for taxes Chief Financial Officer gave up 6,515 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Executive Officer gave up 17,829 shares (to pay taxes)
  20. 4 Shares withheld for taxes EVP, Chief Commercial Officer gave up 5,689 shares (to pay taxes)

Page 3 of 26 · 513 filings